V

Voxel SA
WSE:VOX

Watchlist Manager
Voxel SA
WSE:VOX
Watchlist
Price: 175 PLN 2.1% Market Closed
Market Cap: 1.8B PLN

Profitability Summary

Voxel SA's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Voxel SA

Revenue
557m PLN
Cost of Revenue
-396.3m PLN
Gross Profit
160.7m PLN
Operating Expenses
-26.7m PLN
Operating Income
133.9m PLN
Other Expenses
-32.5m PLN
Net Income
101.5m PLN

Margins Comparison
Voxel SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
PL
Voxel SA
WSE:VOX
1.8B PLN
29%
24%
18%
US
Cigna Group
XMUN:CGN
70.3B EUR
10%
4%
2%
US
Cigna Corp
NYSE:CI
81.8B USD
10%
4%
2%
US
CVS Health Corp
NYSE:CVS
81.2B USD
14%
3%
1%
DE
Fresenius Medical Care AG
XMUN:FME
27.2B EUR
24%
7%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
23.6B EUR
24%
9%
2%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.9B USD
28%
9%
6%
US
Quest Diagnostics Inc
NYSE:DGX
18.9B USD
33%
14%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.6B EUR
24%
7%
3%
US
Hims & Hers Health Inc
NYSE:HIMS
11.6B USD
77%
6%
9%
US
DaVita Inc
NYSE:DVA
11.1B USD
32%
15%
7%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Voxel SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
PL
Voxel SA
WSE:VOX
1.8B PLN
29%
17%
28%
21%
US
Cigna Group
XMUN:CGN
70.3B EUR
12%
3%
10%
6%
US
Cigna Corp
NYSE:CI
81.8B USD
12%
3%
10%
6%
US
CVS Health Corp
NYSE:CVS
81.2B USD
7%
2%
6%
4%
DE
Fresenius Medical Care AG
XMUN:FME
27.2B EUR
4%
2%
5%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
23.6B EUR
2%
1%
5%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.9B USD
9%
4%
8%
6%
US
Quest Diagnostics Inc
NYSE:DGX
18.9B USD
13%
6%
11%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.6B EUR
4%
2%
5%
3%
US
Hims & Hers Health Inc
NYSE:HIMS
11.6B USD
37%
25%
24%
48%
US
DaVita Inc
NYSE:DVA
11.1B USD
261%
5%
13%
10%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less